Company Filing History:
Years Active: 2014
Title: H C Wu: Innovator in Cancer Treatment
Introduction
H C Wu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on developing cancer-targeting peptides that have the potential to improve diagnosis and treatment options for patients.
Latest Patents
H C Wu holds a patent for "Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis." This patent describes cancer-targeting peptides featuring a PXLX motif, where X is either His or an amino acid residue with a hydrophobic side chain, and X is Pro, Phe, or Trp. The patent also discloses conjugates containing these cancer-targeting peptides and their applications in cancer treatment and diagnosis. He has 1 patent to his name.
Career Highlights
H C Wu is affiliated with Academia Sinica, a leading research institution in Taiwan. His work at Academia Sinica has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in cancer therapies.
Collaborations
Some of his notable coworkers include John Yu and Alice L Yu. Their collaborative efforts have further advanced the research and development of innovative cancer treatments.
Conclusion
H C Wu's contributions to cancer treatment through his patented innovations highlight the importance of research in improving healthcare outcomes. His work continues to inspire advancements in the field of oncology.